EMA Endorses Dexamethasone For COVID-19
The Move Should Speed Up EU National Approvals
Companies marketing dexamethasone in Europe have been told they can use a CHMP endorsement to request the addition of COVID-19 to their product license.
You may also be interested in...
WHO’s Latest COVID Recommendations Show Generic Potential
World Health Organization recommendations to use dexamethasone and hydrocortisone to treat patients with severe and critical COVID-19 demonstrate the potential for common and low-cost generics in fighting the coronavirus pandemic.
COVID-19: Mystery Company Eyes EU Approval For Dexamethasone Taw
The European Medicines Agency has started reviewing under its fast-track pathway an application to market Dexamethasone Taw as a treatment for hospitalized patients with COVID-19.
Dexamethasone Shows Potential Of Repurposed Generics Against COVID-19
Positive trial results for dexamethasone in treating COVID-19 patients demonstrate the potential of repurposing existing generic medicines to fight the coronavirus pandemic.